was read the article
array:25 [ "pii" => "S002175571730044X" "issn" => "00217557" "doi" => "10.1016/j.jped.2017.07.006" "estado" => "S300" "fechaPublicacion" => "2018-09-01" "aid" => "564" "copyright" => "Sociedade Brasileira de Pediatria" "copyrightAnyo" => "2017" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "fla" "cita" => "J Pediatr (Rio J). 2018;94:504-10" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 809 "formatos" => array:3 [ "EPUB" => 77 "HTML" => 510 "PDF" => 222 ] ] "Traduccion" => array:1 [ "pt" => array:20 [ "pii" => "S2255553617301337" "issn" => "22555536" "doi" => "10.1016/j.jpedp.2017.09.019" "estado" => "S300" "fechaPublicacion" => "2018-09-01" "aid" => "564" "copyright" => "Sociedade Brasileira de Pediatria" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "fla" "cita" => "J Pediatr (Rio J). 2018;94:504-10" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 1219 "formatos" => array:3 [ "EPUB" => 83 "HTML" => 846 "PDF" => 290 ] ] "pt" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Artigo Original</span>" "titulo" => "Hepatobiliary disease in children and adolescents with cystic fibrosis" "tienePdf" => "pt" "tieneTextoCompleto" => "pt" "tieneResumen" => array:2 [ 0 => "en" 1 => "pt" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "504" "paginaFinal" => "510" ] ] "titulosAlternativos" => array:1 [ "pt" => array:1 [ "titulo" => "Doença hepatobiliar em crianças e adolescentes com fibrose cística" ] ] "contieneResumen" => array:2 [ "en" => true "pt" => true ] "contieneTextoCompleto" => array:1 [ "pt" => true ] "contienePdf" => array:1 [ "pt" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Fernanda de S. Nascimento, Nelson A. Sena, Tatiane da A. Ferreira, Cibele D.F. Marques, Luciana R. Silva, Edna Lúcia Souza" "autores" => array:6 [ 0 => array:2 [ "nombre" => "Fernanda de S." "apellidos" => "Nascimento" ] 1 => array:2 [ "nombre" => "Nelson A." "apellidos" => "Sena" ] 2 => array:2 [ "nombre" => "Tatiane da A." "apellidos" => "Ferreira" ] 3 => array:2 [ "nombre" => "Cibele D.F." "apellidos" => "Marques" ] 4 => array:2 [ "nombre" => "Luciana R." "apellidos" => "Silva" ] 5 => array:2 [ "nombre" => "Edna Lúcia" "apellidos" => "Souza" ] ] ] ] ] "idiomaDefecto" => "pt" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S002175571730044X" "doi" => "10.1016/j.jped.2017.07.006" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S002175571730044X?idApp=UINPBA000049" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2255553617301337?idApp=UINPBA000049" "url" => "/22555536/0000009400000005/v2_201810250609/S2255553617301337/v2_201810250609/pt/main.assets" ] ] "itemSiguiente" => array:20 [ "pii" => "S0021755717302024" "issn" => "00217557" "doi" => "10.1016/j.jped.2017.07.013" "estado" => "S300" "fechaPublicacion" => "2018-09-01" "aid" => "577" "copyright" => "Sociedade Brasileira de Pediatria" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "fla" "cita" => "J Pediatr (Rio J). 2018;94:511-7" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 698 "formatos" => array:3 [ "EPUB" => 97 "HTML" => 403 "PDF" => 198 ] ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>" "titulo" => "Parents’ use of physical and verbal punishment: cross-sectional study in underprivileged neighborhoods" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "pt" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "511" "paginaFinal" => "517" ] ] "titulosAlternativos" => array:1 [ "pt" => array:1 [ "titulo" => "Uso de disciplina física e verbal pelos pais: estudo transversal em bairros vulneráveis" ] ] "contieneResumen" => array:2 [ "en" => true "pt" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2085 "Ancho" => 2889 "Tamanyo" => 337724 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Estimated proportion of different forms of discipline used by both parents.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Vagner dos Santos, Paulo Henrique Dourado da Silva, Lenora Gandolfi" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Vagner dos" "apellidos" => "Santos" ] 1 => array:2 [ "nombre" => "Paulo Henrique Dourado da" "apellidos" => "Silva" ] 2 => array:2 [ "nombre" => "Lenora" "apellidos" => "Gandolfi" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "pt" => array:9 [ "pii" => "S2255553617301672" "doi" => "10.1016/j.jpedp.2017.10.004" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "pt" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2255553617301672?idApp=UINPBA000049" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0021755717302024?idApp=UINPBA000049" "url" => "/00217557/0000009400000005/v1_201810100616/S0021755717302024/v1_201810100616/en/main.assets" ] "itemAnterior" => array:20 [ "pii" => "S0021755717301870" "issn" => "00217557" "doi" => "10.1016/j.jped.2017.06.019" "estado" => "S300" "fechaPublicacion" => "2018-09-01" "aid" => "568" "copyright" => "Sociedade Brasileira de Pediatria" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "fla" "cita" => "J Pediatr (Rio J). 2018;94:498-503" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 861 "formatos" => array:3 [ "EPUB" => 74 "HTML" => 441 "PDF" => 346 ] ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>" "titulo" => "Weaning practices of mothers in eastern Turkey" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "pt" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "498" "paginaFinal" => "503" ] ] "titulosAlternativos" => array:1 [ "pt" => array:1 [ "titulo" => "Práticas maternas de desmame no leste da Turquia" ] ] "contieneResumen" => array:2 [ "en" => true "pt" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Nazan Gürarslan Baş, Gülnaz Karatay, Duygu Arikan" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Nazan" "apellidos" => "Gürarslan Baş" ] 1 => array:2 [ "nombre" => "Gülnaz" "apellidos" => "Karatay" ] 2 => array:2 [ "nombre" => "Duygu" "apellidos" => "Arikan" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "pt" => array:9 [ "pii" => "S2255553617301453" "doi" => "10.1016/j.jpedp.2017.09.029" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "pt" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2255553617301453?idApp=UINPBA000049" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0021755717301870?idApp=UINPBA000049" "url" => "/00217557/0000009400000005/v1_201810100616/S0021755717301870/v1_201810100616/en/main.assets" ] "en" => array:19 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>" "titulo" => "Hepatobiliary disease in children and adolescents with cystic fibrosis" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "504" "paginaFinal" => "510" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Fernanda de S. Nascimento, Nelson A. Sena, Tatiane da A. Ferreira, Cibele D.F. Marques, Luciana R. Silva, Edna Lúcia Souza" "autores" => array:6 [ 0 => array:3 [ "nombre" => "Fernanda de S." "apellidos" => "Nascimento" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 1 => array:3 [ "nombre" => "Nelson A." "apellidos" => "Sena" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 2 => array:3 [ "nombre" => "Tatiane da A." "apellidos" => "Ferreira" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] ] ] 3 => array:3 [ "nombre" => "Cibele D.F." "apellidos" => "Marques" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "aff0020" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">e</span>" "identificador" => "aff0025" ] ] ] 4 => array:3 [ "nombre" => "Luciana R." "apellidos" => "Silva" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">f</span>" "identificador" => "aff0030" ] ] ] 5 => array:4 [ "nombre" => "Edna Lúcia" "apellidos" => "Souza" "email" => array:1 [ 0 => "souza.ednalucia@gmail.com" ] "referencia" => array:3 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">g</span>" "identificador" => "aff0035" ] 2 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] ] "afiliaciones" => array:7 [ 0 => array:3 [ "entidad" => "Complexo Hospitalar Professor Edgard Santos, Salvador, BA, Brazil" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Universidade Federal da Bahia (UFBA), Salvador, BA, Brazil" "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "Complexo Hospitalar Professor Edgard Santos, Serviço de Pneumologia Pediátrica, Salvador, BA, Brazil" "etiqueta" => "c" "identificador" => "aff0015" ] 3 => array:3 [ "entidad" => "Universidade Federal da Bahia (UFBA), Faculdade de Medicina, Salvador, BA, Brazil" "etiqueta" => "d" "identificador" => "aff0020" ] 4 => array:3 [ "entidad" => "Complexo Hospitalar Professor Edgard Santos, Programa de Residência Médica em Gastropediatria, Salvador, BA, Brazil" "etiqueta" => "e" "identificador" => "aff0025" ] 5 => array:3 [ "entidad" => "Universidade Federal da Bahia (UFBA), Serviço de Gastroenterologia e Hepatologia, Salvador, BA, Brazil" "etiqueta" => "f" "identificador" => "aff0030" ] 6 => array:3 [ "entidad" => "Universidade Federal da Bahia (UFBA), Faculdade de Medicina, Departamento de Pediatria, Salvador, BA, Brazil" "etiqueta" => "g" "identificador" => "aff0035" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "pt" => array:1 [ "titulo" => "Doença hepatobiliar em crianças e adolescentes com fibrose cística" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0065">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">Cystic fibrosis (CF) is the most common lethal genetic disease in white individuals. Abnormal chlorine and sodium transport through the defective cystic fibrosis transmembrane conductance regulator (CFTR) protein causes an increase in the density of exocrine secretions, affecting several organs.<a class="elsevierStyleCrossRef" href="#bib0135"><span class="elsevierStyleSup">1</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">The main clinical manifestations of CF are concentrated in the respiratory and gastrointestinal tracts. However, with the increase in the life expectancy of CF patients in the last decades, the prevalence of CF-associated hepatobiliary disease has increased and attracted more attention of patients, family members, and healthcare professionals.<a class="elsevierStyleCrossRefs" href="#bib0140"><span class="elsevierStyleSup">2,3</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">Usually, hepatobiliary manifestations associated with CF start at the end of the patients’ first decade of life, and its prevalence ranges from 5.7% to 39%.<a class="elsevierStyleCrossRefs" href="#bib0150"><span class="elsevierStyleSup">4–11</span></a> Hepatobiliary disease is the third leading cause of mortality in CF patients, preceded by deaths associated with pulmonary involvement and complications inherent to organ transplants.<a class="elsevierStyleCrossRef" href="#bib0190"><span class="elsevierStyleSup">12</span></a> Additionally, some studies have shown that patients with advanced liver disease are at risk of developing and/or exacerbating other extrahepatic CF manifestations, such as malnutrition, diabetes mellitus, hepatic osteodystrophy, and pulmonary disease, leading to increased morbidity caused by the underlying disease.<a class="elsevierStyleCrossRefs" href="#bib0145"><span class="elsevierStyleSup">3,13</span></a> Thus, hepatobiliary disease has been considered a risk predictor of an unfavorable evolution and prognosis of CF.<a class="elsevierStyleCrossRef" href="#bib0200"><span class="elsevierStyleSup">14</span></a></p><p id="par0020" class="elsevierStylePara elsevierViewall">Few studies have been carried out on CF-associated hepatobiliary disease in the Brazilian population, being fundamental to know the disease particularities in Brazil, which has peculiar ethnic/racial characteristics in the different geographic regions. The objectives of the study were to determine the frequency of hepatobiliary disease in CF patients and to describe the sociodemographic, clinical, and laboratory profile of these patients.</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0070">Methods</span><p id="par0025" class="elsevierStylePara elsevierViewall">This was a retrospective, descriptive, and analytical study of patients treated at a referral center in a university hospital. The records of all patients, aged 3 months to 21 years, followed-up between January 2008 and June 2016, with a diagnosis of CF confirmed by two positive sweat tests and/or genetic study, and who had been followed-up for at least three months in this service, were analyzed.</p><p id="par0030" class="elsevierStylePara elsevierViewall">Patients with comorbidities that affected the hepatobiliary system (use of hepatotoxic drugs and/or primary hepatobiliary diseases, or secondary involvement of the liver, gallbladder, and/or spleen) were excluded.</p><p id="par0035" class="elsevierStylePara elsevierViewall">Data were collected from medical records between June and July 2016, consisting of sociodemographic and clinical characteristics – age (months), weight (kg), height (cm), and body mass index (BMI) at CF diagnosis; time of follow-up at the service; presence of hepatobiliary (jaundice, hepatomegaly, splenomegaly, collateral circulation), pulmonary (recurrent pneumonia, wheezing, colonization by <span class="elsevierStyleItalic">Pseudomonas aeruginosa</span>), and gastrointestinal (diarrhea, steatorrhea, low weight gain, meconium ileus) manifestations; Shwachman–Kulczycki score,<a class="elsevierStyleCrossRef" href="#bib0205"><span class="elsevierStyleSup">15</span></a> laboratory/imaging tests, and genetic study.</p><p id="par0040" class="elsevierStylePara elsevierViewall">Information on histopathological tests (liver biopsy) and upper digestive endoscopy (UDE) were recorded, when present. Weight, height, and BMI were evaluated by <span class="elsevierStyleItalic">Z</span>-score, according to the World Health Organization (WHO, 2006) classification. Patients with fecal elastase <100<span class="elsevierStyleHsp" style=""></span>μg/g were classified as having severe pancreatic insufficiency. Abdominal ultrasonography (USG) was performed annually in patients older than 7 years, or earlier in those with signs, symptoms, or alterations in laboratory tests suggestive of hepatobiliary disease.</p><p id="par0045" class="elsevierStylePara elsevierViewall">The age at the CF diagnosis was defined as the time of the second positive sweat test or genetic study result. The time of follow-up of each patient corresponded to the period between June 2016 and the first consultation or first hospitalization at the service. Skin color was defined by one of the researchers, medical coordinator of the multidisciplinary CF outpatient clinic, based on the phenotypic characteristics of the patients and their parents.</p><p id="par0050" class="elsevierStylePara elsevierViewall">All patients underwent a genetic study, and the following mutations in the <span class="elsevierStyleItalic">CFTR</span> gene were screened through polymerase chain reaction (PCR) or enzymatic digestion<a class="elsevierStyleCrossRef" href="#bib0210"><span class="elsevierStyleSup">16</span></a>: F508del, G542X, R1162X, R334W, 3120+1G-A, G551D, and R553X. Infection by cytomegalovirus (CMV) was investigated through serological tests (IgM and IgG antibodies) in patients with hepatobiliary disease criteria, whereas PCR was also performed, when available.</p><p id="par0055" class="elsevierStylePara elsevierViewall">CF-associated hepatobiliary disease was defined as compatible alterations at the liver biopsy or evidence of cholangiopathy (microvesicles, biliary lithiasis, or bile duct stenosis) or the presence, for three consecutive months, of at least two of the following criteria: (1) hepatomegaly on physical examination (liver >2<span class="elsevierStyleHsp" style=""></span>cm from the right costal border, confirmed by abdominal USG); (2) elevation above the upper limit of normal of aspartate aminotransferase and/or alanine aminotransferase and/or gamma-glutamyl transferase levels; and (3) alteration in the abdominal USG (increased hepatic echogenicity, nodularity, irregular liver border, liver fibrosis, or portal hypertension signs).<a class="elsevierStyleCrossRef" href="#bib0165"><span class="elsevierStyleSup">7</span></a> The age at diagnosis of hepatobiliary disease was determined at the moment when some of the criteria were observed.</p><p id="par0060" class="elsevierStylePara elsevierViewall">The software SPSS<span class="elsevierStyleSup">®</span> (IBM SPSS Statistics for Windows, Version 20.0, NY, USA), was used to create the database and carry out the statistical analysis. The descriptive analysis of sociodemographic, clinical, and laboratory characteristics, characterized by measures of central tendency and dispersion (means and standard deviation, median and interquartile range) was performed, as well as the comparison of groups with and without hepatobiliary disease using the Mann–Whitney test for numerical variables and Fisher's exact test for categorical variables. <span class="elsevierStyleItalic">p</span>-values ≤0.05 were considered statistically significant in all analyses.</p><p id="par0065" class="elsevierStylePara elsevierViewall">The study was approved by the Research Ethics Committee of the institution, under registration number 121/2011. All participants and their guardians received verbal and written information about the nature, proposal, and objective of the study and its possible risks and benefits, and signed the informed consent form.</p></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">Results</span><p id="par0070" class="elsevierStylePara elsevierViewall">A total of 55 patients with CF were analyzed. The median (IQR) of the follow-up time of these patients was 35 (15–78) months, ranging from three to 102 months. The distribution of the number of new CF and hepatobiliary disease cases per year of follow-up is shown in <a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>.</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0075" class="elsevierStylePara elsevierViewall">CF-associated hepatobiliary disease was diagnosed in 16.4% (9/55) of CF patients. The median age (IQR) of these patients was 54 (27–91) months, ranging from 10 months to 9 years and 11 months. Seven (77.8%) patients were females; and all were considered non-white. The other sociodemographic, clinical, and laboratory characteristics of the group of CF patients with and without hepatobiliary disease are shown in <a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>.</p><elsevierMultimedia ident="tbl0010"></elsevierMultimedia><p id="par0080" class="elsevierStylePara elsevierViewall">The median age (IQR) at the diagnosis of hepatobiliary disease associated with CF was 7 months (3–47). This diagnosis occurred before and/or concomitantly with that of CF in 88.9% of the patients, and the presence of hepatobiliary manifestations was among the first signs and symptoms of CF in five of the nine patients (55.6%).</p><p id="par0085" class="elsevierStylePara elsevierViewall">Patients with hepatopathy had a higher frequency of severe mutations in the <span class="elsevierStyleItalic">CFTR</span> gene (77.8% <span class="elsevierStyleItalic">vs</span>. 39.6%, <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.033) and severe pancreatic insufficiency (88.9% <span class="elsevierStyleItalic">vs</span>. 31.6%, <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.007) than the group without hepatobiliary disease. Although not statistically significant, the children with hepatobiliary disease had a much earlier CF diagnosis in comparison with the second group, with a median (IQR) of 7 (4.5–47) <span class="elsevierStyleItalic">vs</span>. 59 (7–104.5) months, respectively (<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.059; <a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>).</p><p id="par0090" class="elsevierStylePara elsevierViewall">Regarding the clinical characteristics of the nine patients with CF-associated hepatobiliary disease, no cases with meconium ileus were observed, and one patient had normal pancreatic function with asymptomatic biliary disease. The others (88.9%) had severe pancreatic insufficiency.</p><p id="par0095" class="elsevierStylePara elsevierViewall"><a class="elsevierStyleCrossRef" href="#tbl0015">Table 3</a> shows the clinical characteristics at the time of CF diagnosis of patients with hepatobiliary disease. Some nutritional impairment (<span class="elsevierStyleItalic">Z</span>-score for weight/age and/or height/age and/or BMI/age <−2) was observed in six (66.7%) of these patients. The medians of <span class="elsevierStyleItalic">Z</span>-scores for weight/age and height/age in this group of patients were −3.27 and −3.08, with minimum values of −9.49 and −6.82, respectively. The BMI/age <span class="elsevierStyleItalic">Z</span>-scores were >−2 in 77.8% of the cases, due to the proportional reduction in weight and height values (<a class="elsevierStyleCrossRef" href="#tbl0015">Table 3</a>).</p><elsevierMultimedia ident="tbl0015"></elsevierMultimedia><p id="par0100" class="elsevierStylePara elsevierViewall">The type of presentation of CF-associated hepatobiliary disease is described in <a class="elsevierStyleCrossRef" href="#tbl0020">Table 4</a>. Hepatomegaly was the most frequently identified finding, in seven patients (77.8%), followed by increased hepatic echogenicity in five children (55.5%). All patients underwent CMV screening, which was positive in two cases, one of which was also confirmed by PCR. One patient with negative serology had CMV infection confirmed by PCR. These patients had liver biopsy findings compatible with CF-associated hepatobiliary disease. Regarding the complications of hepatopathy, portal hypertension was observed in two patients, splenomegaly in only one case, and esophageal varices in one of the four patients who underwent UDE. Only one child developed signs of acute liver failure.</p><elsevierMultimedia ident="tbl0020"></elsevierMultimedia></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080">Discussion</span><p id="par0105" class="elsevierStylePara elsevierViewall">The present study demonstrated that 16.4% of the patients with CF had hepatobiliary disease. This frequency is similar to that described by Wagener et al. (16.3%), who evaluated 30,727 CF patients from a multicenter study in the United States and Canada between 1999 and 2004.<a class="elsevierStyleCrossRef" href="#bib0180"><span class="elsevierStyleSup">10</span></a> However, Fagundes et al. followed-up 106 Brazilian patients with CF for approximately one year and found a lower frequency (9.4%) of hepatobiliary disease associated with CF.<a class="elsevierStyleCrossRef" href="#bib0140"><span class="elsevierStyleSup">2</span></a> In addition to the short follow-up period, those authors used only biochemical and/or clinical alterations as diagnostic criteria, which may have led to the underdiagnosis of this complication.</p><p id="par0110" class="elsevierStylePara elsevierViewall">The prevalence of CF-associated hepatobiliary disease is quite variable in the literature, due to the heterogeneous clinical presentation, absence of universal diagnostic criteria, and the variation of characteristics inherent to the population (age, gender, survival rate).<a class="elsevierStyleCrossRef" href="#bib0215"><span class="elsevierStyleSup">17</span></a> Longitudinal studies in Europeans, North-Americans, and Brazilians have shown prevalence rates varying between 5.7% and 39%.<a class="elsevierStyleCrossRefs" href="#bib0150"><span class="elsevierStyleSup">4–11</span></a></p><p id="par0115" class="elsevierStylePara elsevierViewall">Male gender has been considered a risk factor for the development of hepatobiliary disease associated with CF. Colombo et al. demonstrated a 2.5-fold higher risk of hepatobiliary disease in males.<a class="elsevierStyleCrossRef" href="#bib0165"><span class="elsevierStyleSup">7</span></a> However, the present study showed a higher frequency of males in the group without hepatobiliary disease (<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.042). The predominance of females among the patients with hepatobiliary disease (77.8%) is in agreement with data from the study by Lindblad et al., in which 68.6% of patients with CF and hepatopathy were females.<a class="elsevierStyleCrossRef" href="#bib0160"><span class="elsevierStyleSup">6</span></a></p><p id="par0120" class="elsevierStylePara elsevierViewall">In this study, the age at the diagnosis of hepatobiliary disease associated with CF was early (median of 7 months), ranging from 3 months to 3 years and 11 months; hepatobiliary manifestations were among the first signs and symptoms of CF in 55.6% (5/9) of these patients. Additionally, it is important to emphasize that the diagnosis of hepatobiliary disease occurred before and/or concomitantly with that of CF in 88.9% (8/9) of them.</p><p id="par0125" class="elsevierStylePara elsevierViewall">However, Ciucã et al., when studying 66 Romanians with CF, demonstrated that only three patients (4.5%) had hepatobiliary disease as the first manifestation of CF, with a mean interval of four years between the CF diagnosis and hepatopathy.<a class="elsevierStyleCrossRef" href="#bib0220"><span class="elsevierStyleSup">18</span></a> Other studies have also demonstrated a later onset of hepatobiliary disease, ranging from 3 to 8 years.<a class="elsevierStyleCrossRefs" href="#bib0140"><span class="elsevierStyleSup">2,7–9,18,19</span></a> Therefore, the findings of the present study demonstrate the early onset of this manifestation in this population of patients with CF and the importance of investigating CF in patients with hepatopathy.</p><p id="par0130" class="elsevierStylePara elsevierViewall">Among the possible justifications for the early presentation is the fact that patients with hepatobiliary disease have more severe CF phenotypes, which was corroborated by the association between the presence of severe pancreatic insufficiency (88.9% <span class="elsevierStyleItalic">vs</span>. 31.6%; <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.007) and severe mutations in the <span class="elsevierStyleItalic">CFTR</span> gene (77.8% <span class="elsevierStyleItalic">vs</span>. 39.6%, <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.033) in this group, compared to those without hepatobiliary disease.</p><p id="par0135" class="elsevierStylePara elsevierViewall">Moreover, Lamireau et al. demonstrated that pancreatic insufficiency is an independent factor associated with an increased prevalence of hepatobiliary disease in CF, leading to a 9.8-fold higher risk of liver disease in patients with CF.<a class="elsevierStyleCrossRef" href="#bib0170"><span class="elsevierStyleSup">8</span></a> Although the literature does not describe an association between any mutation related to the <span class="elsevierStyleItalic">CFTR</span> gene and the presence or severity of hepatobiliary disease, some studies have demonstrated that more severe genotypes may be considered risk factors.<a class="elsevierStyleCrossRefs" href="#bib0230"><span class="elsevierStyleSup">20,21</span></a></p><p id="par0140" class="elsevierStylePara elsevierViewall">Cirrhosis occurs predominantly in individuals with Class I, II, and III mutations.<a class="elsevierStyleCrossRefs" href="#bib0135"><span class="elsevierStyleSup">1,10,22,23</span></a> A study of 174 Romanians with CF disclosed a five-fold higher risk of developing hepatobiliary disease in patients with severe mutations (OR: 4.79), which were identified in 78% of those with hepatobiliary disease.<a class="elsevierStyleCrossRef" href="#bib0220"><span class="elsevierStyleSup">18</span></a> However, it is known that liver disease development is very variable among patients with the same <span class="elsevierStyleItalic">CFTR</span> mutations, suggesting a possible multigenic role of the genetic polymorphism and environmental factors, not evaluated in the study, in the pathogenesis of this complication.<a class="elsevierStyleCrossRefs" href="#bib0135"><span class="elsevierStyleSup">1,3,13,21,24</span></a> Therefore, later studies may assess the role of these variables in the development of hepatobiliary disease.</p><p id="par0145" class="elsevierStylePara elsevierViewall">Poor lung function and nutritional status indicators in CF have also been studied as risk factors for hepatobiliary disease, and could justify the severity and early onset of this complication. Fagundes et al. identified an association between W/A <span class="elsevierStyleItalic">Z</span>-score <−2 and development of hepatobiliary disease; these authors also observed that Shwachman–Kulczycki score values ≤70 conferred a 7.5-fold higher risk of developing this complication in patients with CF.<a class="elsevierStyleCrossRef" href="#bib0255"><span class="elsevierStyleSup">25</span></a> In the present study, 44.4% of the patients with hepatobiliary disease presented Shwachman–Kulczycki score ≤70, and some degree of nutritional impairment was observed in 66.7% of them. However, it is necessary to compare these variables with the group without hepatobiliary disease to reinforce the importance of these findings.</p><p id="par0150" class="elsevierStylePara elsevierViewall">Although not statistically significant, it is worth mentioning that the CF diagnosis was attained much earlier in the group with hepatobiliary disease, when compared to those without this complication (median of 7 <span class="elsevierStyleItalic">vs</span>. 59 months, <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.059). Similarly, Fagundes et al. demonstrated that the age at CF diagnosis was independently associated with the development of liver disease, being inversely proportional.<a class="elsevierStyleCrossRef" href="#bib0255"><span class="elsevierStyleSup">25</span></a></p><p id="par0155" class="elsevierStylePara elsevierViewall">It is possible that hepatobiliary disease is part of a spectrum of worse prognosis and severity of CF, which would justify the earlier disease diagnosis in these patients. It is possible that a larger sample could demonstrate this association, since this study evaluated only 55 children.</p><p id="par0160" class="elsevierStylePara elsevierViewall">Liver disease with cirrhosis and its complications tend to occur in approximately 7–12% of CF patients between the ages of 7 and 10.<a class="elsevierStyleCrossRefs" href="#bib0160"><span class="elsevierStyleSup">6,18,19</span></a> Lamireau et al. demonstrated a median time of 10 years for the evolution of hepatopathy associated with CF to portal hypertension. In the present study, only two patients with CF (3.6%), who already had portal hypertension since the diagnosis, presented liver cirrhosis at 5 months and 3 years of age. Non-performance of hepatic biopsy in all patients and the young age of children with hepatobiliary disease (median of 7 months) may justify the lower frequency of cirrhosis, since it is a late consequence, secondary to progressive hepatocyte lesion due to biliary thickening and its toxicity.<a class="elsevierStyleCrossRef" href="#bib0215"><span class="elsevierStyleSup">17</span></a></p><p id="par0165" class="elsevierStylePara elsevierViewall">However, it is noteworthy the precocity of cirrhosis and portal hypertension onset in the present study, suggesting a more severe spectrum of liver disease in this population. A possible justification would be the presence of concomitant CMV infection, worsening the liver status. This infection occurs in 50% of the children in the first year of life in places with high seropositivity rates,<a class="elsevierStyleCrossRef" href="#bib0260"><span class="elsevierStyleSup">26</span></a> which is associated with precarious socioeconomic conditions (found in the studied population). However, this association has not been confirmed. In turn, although this infection was investigated in all patients through serology, only two were identified using the PCR technique and, thus, underdiagnosis may have occurred.</p><p id="par0170" class="elsevierStylePara elsevierViewall">Among the study limitations, the authors emphasize the small sample of patients with CF and the number of patients with hepatobiliary disease. Moreover, only four patients underwent a liver biopsy, which may have underestimated the occurrence of liver disease. Additionally, it was not possible to confirm the genetic diagnosis of CF in all patients, since only seven mutations were investigated. Furthermore, the role of genetic polymorphisms in the development of this complication was not evaluated. Nonetheless, the results were significant.</p><p id="par0175" class="elsevierStylePara elsevierViewall">In conclusion, this study found a high frequency of hepatobiliary disease in patients with CF (16.4%), which occurred as an initial manifestation of the latter in 55.6% of patients with liver disease. It is worth mentioning the earlier occurrence of hepatobiliary disease, as well as the early onset of complications in relation to the literature. This emphasizes the importance of including CF in the differential diagnosis of all liver diseases in childhood. Additionally, an association was observed between the presence of pancreatic insufficiency and severe mutations in the <span class="elsevierStyleItalic">CFTR</span> gene and the occurrence of hepatobiliary disease. However, further studies involving a larger number of patients should be carried out, aiming to better assess other risk factors for the development of hepatobiliary disease in CF.</p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Funding</span><p id="par0180" class="elsevierStylePara elsevierViewall">Partial funding from <span class="elsevierStyleGrantSponsor" id="gs1">Fundação de Amparo à Pesquisa do Estado da Bahia (FAPESB)</span> under No. <span class="elsevierStyleGrantNumber" refid="gs1">020/2013</span> – Programa de Pesquisa para o SUS da Bahia: gestão partilhada de saúde – FAPESB.</p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0090">Conflicts of interest</span><p id="par0185" class="elsevierStylePara elsevierViewall">The authors declare no conflicts of interest.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:11 [ 0 => array:3 [ "identificador" => "xres1092877" "titulo" => "Abstract" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0005" "titulo" => "Objectives" ] 1 => array:2 [ "identificador" => "abst0010" "titulo" => "Methods" ] 2 => array:2 [ "identificador" => "abst0015" "titulo" => "Results" ] 3 => array:2 [ "identificador" => "abst0020" "titulo" => "Conclusion" ] ] ] 1 => array:2 [ "identificador" => "xpalclavsec1035738" "titulo" => "Keywords" ] 2 => array:3 [ "identificador" => "xres1092876" "titulo" => "Resumo" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0025" "titulo" => "Objetivos" ] 1 => array:2 [ "identificador" => "abst0030" "titulo" => "Métodos" ] 2 => array:2 [ "identificador" => "abst0035" "titulo" => "Resultados" ] 3 => array:2 [ "identificador" => "abst0040" "titulo" => "Conclusão" ] ] ] 3 => array:2 [ "identificador" => "xpalclavsec1035737" "titulo" => "Palavras-chave" ] 4 => array:2 [ "identificador" => "sec0005" "titulo" => "Introduction" ] 5 => array:2 [ "identificador" => "sec0010" "titulo" => "Methods" ] 6 => array:2 [ "identificador" => "sec0015" "titulo" => "Results" ] 7 => array:2 [ "identificador" => "sec0020" "titulo" => "Discussion" ] 8 => array:2 [ "identificador" => "sec0025" "titulo" => "Funding" ] 9 => array:2 [ "identificador" => "sec0030" "titulo" => "Conflicts of interest" ] 10 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2017-01-18" "fechaAceptado" => "2017-06-30" "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec1035738" "palabras" => array:3 [ 0 => "Mucoviscidosis" 1 => "Hepatopathies" 2 => "Liver" ] ] ] "pt" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palavras-chave" "identificador" => "xpalclavsec1035737" "palabras" => array:3 [ 0 => "Mucoviscidose" 1 => "Hepatopatias" 2 => "Fígado" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:3 [ "titulo" => "Abstract" "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Objectives</span><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">The aims of the study were to determine the frequency of hepatobiliary disease in patients with cystic fibrosis and to describe the sociodemographic, clinical, and laboratory profile of these patients.</p></span> <span id="abst0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Methods</span><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">This was a retrospective, descriptive, and analytical study of 55 patients diagnosed with cystic fibrosis, aged between 3 months and 21 years, followed-up from January 2008 to June 2016 in a referral center. Medical records were consulted and sociodemographic, clinical and laboratory data, including hepatobiliary alterations, imaging studies, genetic studies, liver biopsies, and upper digestive endoscopies were registered.</p></span> <span id="abst0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0020">Results</span><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">Hepatobiliary disease was diagnosed in 16.4% of the patients and occurred as an initial manifestation of cystic fibrosis in 55.6% of these cases. The diagnosis of hepatopathy occurred before or concomitantly with the diagnosis of cystic fibrosis in 88.9% of the children. All patients with hepatobiliary disease were considered non-white, with a predominance of females (77.8%) and median (IQR) of 54 (27–91) months. Compared with the group without hepatobiliary disease, children with liver disease had a higher frequency of severe mutations identified in the <span class="elsevierStyleItalic">CFTR</span> gene (77.8% <span class="elsevierStyleItalic">vs</span>. 39.6%, <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.033) and severe pancreatic insufficiency (88.9% <span class="elsevierStyleItalic">vs</span>. 31.6%, <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.007).</p></span> <span id="abst0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Conclusion</span><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">The frequency of hepatobiliary disease was high, with a very early diagnosis of the disease and its complications in the studied series. A statistical association was observed between the occurrence of hepatobiliary disease and the presence of pancreatic insufficiency and severe mutations in the <span class="elsevierStyleItalic">CFTR</span> gene. It is emphasized that cystic fibrosis is an important differential diagnosis of liver diseases in childhood.</p></span>" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0005" "titulo" => "Objectives" ] 1 => array:2 [ "identificador" => "abst0010" "titulo" => "Methods" ] 2 => array:2 [ "identificador" => "abst0015" "titulo" => "Results" ] 3 => array:2 [ "identificador" => "abst0020" "titulo" => "Conclusion" ] ] ] "pt" => array:3 [ "titulo" => "Resumo" "resumen" => "<span id="abst0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Objetivos</span><p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Os objetivos do estudo foram determinar a frequência da doença hepatobiliar em pacientes com fibrose cística e descrever o perfil sociodemográfico, clínico e laboratorial destes.</p></span> <span id="abst0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Métodos</span><p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Estudo retrospectivo, descritivo e analítico de 55 pacientes com diagnóstico de fibrose cística, entre três meses e 21 anos, acompanhados de janeiro de 2008 a junho de 2016 em um centro de referência. Foi realizada consulta aos prontuários médicos, registrando-se os dados sociodemográficos, clínicos e laboratoriais, incluindo-se alterações hepatobiliares, exames de imagem, estudos genéticos, biópsias hepáticas e endoscopias digestivas altas.</p></span> <span id="abst0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Resultados</span><p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">A doença hepatobiliar foi diagnosticada em 16,4% dos pacientes e ocorreu como manifestação inicial da fibrose cística em 55,6% destes casos. O diagnóstico da hepatopatia ocorreu antes ou concomitante ao diagnóstico da fibrose cística em 88,9% das crianças. Todos os pacientes com doença hepatobiliar foram considerados não brancos, havendo predominância do sexo feminino (77,8%) e mediana (I.I.Q) de idade de 54 (27-91) meses. Em comparação com o grupo sem doença hepatobiliar, as crianças com hepatopatia tiveram maior frequência de mutações graves no gene CFTR identificadas (77,8% vs 39,6%; p<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0,033) e de insuficiência pancreática grave (88,9% vs 31,6%; p<span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0,007).</p></span> <span id="abst0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Conclusão</span><p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">A frequência de doença hepatobiliar foi elevada, observando-se um diagnóstico muito precoce da mesma e de suas complicações na casuística estudada. Houve associação estatística entre a ocorrência de doença hepatobiliar e a presença de insuficiência pancreática e de mutações graves do gene CFTR. Enfatiza-se que a fibrose cística represente um importante diagnóstico diferencial de hepatopatias na infância.</p></span>" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0025" "titulo" => "Objetivos" ] 1 => array:2 [ "identificador" => "abst0030" "titulo" => "Métodos" ] 2 => array:2 [ "identificador" => "abst0035" "titulo" => "Resultados" ] 3 => array:2 [ "identificador" => "abst0040" "titulo" => "Conclusão" ] ] ] ] "NotaPie" => array:2 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0050">Please cite this article as: Nascimento FS, Sena NA, Ferreira TA, Marques CD, Silva LR, Souza EL. Hepatobiliary disease in children and adolescents with cystic fibrosis. J Pediatr (Rio J). 2018;94:504–10.</p>" ] 1 => array:2 [ "etiqueta" => "☆☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0055">Study carried out at Universidade Federal da Bahia (UFBA), Salvador, BA, Brazil.</p>" ] ] "multimedia" => array:4 [ 0 => array:8 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at1" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Year \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">2008 \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">2009 \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">2010 \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">2011 \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">2012 \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">2013 \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">2014 \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">2015 \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">2016 \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">New cases of cystic fibrosis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">9 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">6 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">4 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">4 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">9 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">4 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">16 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">New cases of hepatobiliary disease \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Total number of included cases/year \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">9 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">15 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">18 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">21 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">25 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">34 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">37 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">55 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">55 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top">Deaths \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1868955.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Number of new cases of cystic fibrosis and hepatobiliary disease, deaths and total number of cases followed-up between January 2008 and June 2016 in a referral center.</p>" ] ] 1 => array:8 [ "identificador" => "tbl0010" "etiqueta" => "Table 2" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at2" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:3 [ "leyenda" => "<p id="spar0055" class="elsevierStyleSimplePara elsevierViewall">IQR, interquartile range; <span class="elsevierStyleItalic">N</span>, number of patients.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="" valign="top" scope="col" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Group with hepatobiliary disease (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>9) \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Group without hepatobiliary disease (<span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>46) \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black"><span class="elsevierStyleItalic">p</span>-value \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry " colspan="4" align="left" valign="top"><span class="elsevierStyleBold">Sociodemographic variables</span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Age (months) median (IQR)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">54 (27–91) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">127 (60.5–169.5) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.004<a class="elsevierStyleCrossRef" href="#tblfn0030"><span class="elsevierStyleSup">f</span></a> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Male gender (n/%)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">2 (22.2) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">27 (58.7) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.042<a class="elsevierStyleCrossRef" href="#tblfn0035"><span class="elsevierStyleSup">g</span></a> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Non-white (n/%)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">9 (100) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">46 (100) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">– \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Income (Brazilian reais) median (IQR)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1058.5 (788–2355)<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">a</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1000 (788–1576)<a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">b</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.879<a class="elsevierStyleCrossRef" href="#tblfn0030"><span class="elsevierStyleSup">f</span></a> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " colspan="4" align="left" valign="top"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="table-entry " colspan="4" align="left" valign="top"><span class="elsevierStyleBold">Clinical and laboratory variables</span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Age at cystic fibrosis diagnosis (months) median (IQR)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">7 (4.5–47) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">59 (7–104.5) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.059<a class="elsevierStyleCrossRef" href="#tblfn0030"><span class="elsevierStyleSup">f</span></a> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Time of follow-up (months) median (IQR)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">33 (10–55.5) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">27 (15–83.3) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.169<a class="elsevierStyleCrossRef" href="#tblfn0030"><span class="elsevierStyleSup">f</span></a> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Fecal elastase <15</span><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">μg/</span>g <span class="elsevierStyleItalic">(n/%)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">8 (88.9) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">12 (31.6)<a class="elsevierStyleCrossRef" href="#tblfn0015"><span class="elsevierStyleSup">c</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.007<a class="elsevierStyleCrossRef" href="#tblfn0035"><span class="elsevierStyleSup">g</span></a> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " colspan="4" align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">Mutation in the CFTR gene (n/%)</span><a class="elsevierStyleCrossRef" href="#tblfn0020"><span class="elsevierStyleSup">d</span></a></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>Class I/II<a class="elsevierStyleCrossRef" href="#tblfn0025"><span class="elsevierStyleSup">e</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">7 (77.8) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">17 (36.9) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">0.033<a class="elsevierStyleCrossRef" href="#tblfn0035"><span class="elsevierStyleSup">g</span></a> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleHsp" style=""></span>Not found \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">2 (22.2) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">28 (60.9) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1868957.png" ] ] ] "notaPie" => array:7 [ 0 => array:3 [ "identificador" => "tblfn0005" "etiqueta" => "a" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Data analyzed in <span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>8.</p>" ] 1 => array:3 [ "identificador" => "tblfn0010" "etiqueta" => "b" "nota" => "<p class="elsevierStyleNotepara" id="npar0010">Data analyzed in <span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>39.</p>" ] 2 => array:3 [ "identificador" => "tblfn0015" "etiqueta" => "c" "nota" => "<p class="elsevierStyleNotepara" id="npar0015">Data analyzed in <span class="elsevierStyleItalic">n</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>38.</p>" ] 3 => array:3 [ "identificador" => "tblfn0020" "etiqueta" => "d" "nota" => "<p class="elsevierStyleNotepara" id="npar0020">Mutation screened in the <span class="elsevierStyleItalic">CFTR</span> gene: F508del, G542X, R1162X, R334W, 3120+1G-A, G551D, and R553X.</p>" ] 4 => array:3 [ "identificador" => "tblfn0025" "etiqueta" => "e" "nota" => "<p class="elsevierStyleNotepara" id="npar0025">Presence of at least one mutation class I or II.</p>" ] 5 => array:3 [ "identificador" => "tblfn0030" "etiqueta" => "f" "nota" => "<p class="elsevierStyleNotepara" id="npar0030">Mann–Whitney test.</p>" ] 6 => array:3 [ "identificador" => "tblfn0035" "etiqueta" => "g" "nota" => "<p class="elsevierStyleNotepara" id="npar0035">Fisher's exact test.</p>" ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0050" class="elsevierStyleSimplePara elsevierViewall">Sociodemographic, clinical and laboratory characteristics of patients with cystic fibrosis, followed-up between January 2008 and June 2016, in a referral center.</p>" ] ] 2 => array:8 [ "identificador" => "tbl0015" "etiqueta" => "Table 3" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at3" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:2 [ "leyenda" => "<p id="spar0065" class="elsevierStyleSimplePara elsevierViewall">IQR, interquartile range; <span class="elsevierStyleItalic">N</span>, number of patients.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Weight/age Z-score (median/IQR)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">−3.27 (−4.34 to −0.26) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Height/age Z-score (median/IQR)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">−3.08 (−4.4 to −0.46) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Weight/height Z-score (median/IQR)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">−0.43 (−2.39 to 0.41) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Body Mass Index/age Z-score (median/IQR)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">−0.26 (1.86 to −0.15) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Pulmonary manifestations (n/%)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">9 (100) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleItalic">Shwachman–Kulczycki score value (median/IQR)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">85 (57.5 to 87.5) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " colspan="2" align="left" valign="top"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="table-entry " colspan="2" align="left" valign="top"><span class="elsevierStyleItalic">Shwachman–Kulczycki score classification (n/%)</span></td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Excellent or good (100–71) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">5 (66.6) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Medium (70–56) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">1 (11.1) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="table-entry ; entry_with_role_rowhead " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Moderate or severe (≤55) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">3 (33.3) \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1868954.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0060" class="elsevierStyleSimplePara elsevierViewall">Clinical characteristics at the time of cystic fibrosis diagnosis of patients with hepatobiliary disease, followed between January 2008 and June 2016, at a referral center.</p>" ] ] 3 => array:8 [ "identificador" => "tbl0020" "etiqueta" => "Table 4" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at4" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:2 [ "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Case \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Gender \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Start of hepatobiliary disease<a class="elsevierStyleCrossRef" href="#tblfn0040"><span class="elsevierStyleSup">a</span></a> \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Genotype \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Clinical \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Laboratory<a class="elsevierStyleCrossRef" href="#tblfn0045"><span class="elsevierStyleSup">b</span></a> \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Abdominal USG \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Liver biopsy \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">UDE \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry " align="char" valign="top">1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">M \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">19 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">F508del/3120+1G-A \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Hepatomegaly \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">↑ Persistent aspartate aminotransferase/gamma-glutamyl transferase \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Hepatomegaly \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">– \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">– \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="char" valign="top">2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">F \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">35 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">F508del/G542X \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Hepatomegaly<br>Collateral circulation \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">↑ Persistent Alkaline Phosphatase<br>↓ Persistent prothrombin time \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Hepatosplenomegaly<br>↑ of hepatic echogenicity<br>Microvesicles<br>Portal hypertension \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Biliary cirrhosis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Esophageal varices \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="char" valign="top">3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">M \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">88 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">F508del/F508del \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Hepatomegaly<br>Jaundice<br>Collateral circulation \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">↑ Persistent aspartate aminotransferase/alanine aminotransferase \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Hepatomegaly<br>↑ of hepatic echogenicity<br>Lobular liver \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Liver steatosis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Normal \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="char" valign="top">4 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">F \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">4 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Not found \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Absent \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Normal \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Biliary lithiasis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">– \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">– \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="char" valign="top">5 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">F \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Not found \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Hepatomegaly<br>Jaundice/Choluria<br>Fecal acolia \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">↑ Transient aspartate aminotransferase/alanine aminotransferase/gamma-glutamyl transferase \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Normal \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Intrahepatic cholestasis<br>Bile in portal space \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">– \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="char" valign="top">6 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">F \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">F508del/F508del \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Hepatomegaly \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">↑ Persistent Alkaline Phosphatase \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Hepatomegaly \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">– \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">– \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="char" valign="top">7 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">F \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">59 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">F 508del/3120+1G-A \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Hepatomegaly \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">↑ Persistent Alkaline Phosphatase<br>↓ Persistent prothrombin time \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Hepatomegaly<br>↑ of hepatic echogenicity<br>Liver steatosis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Fibrosis portal/septal and presinusoidal \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Normal \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="char" valign="top">8 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">F \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">G542X/R1162X \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Hepatomegaly<br>Jaundice/Choluria<br>Fecal acolia<br>Collateral circulation \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">↑ Persistent aspartate aminotransferase/alanine aminotransferase<br>Alkaline Phosphatase/gamma-glutamyl transferase/direct bilirubin<br>↓ Persistent prothrombin time/Albumin \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Hepatomegaly<br>↑ of hepatic echogenicity<br>Nodular liver and irregular border<br>Portal hypertension \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Biliary cirrhosis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">– \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="char" valign="top">9 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">F \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="char" valign="top">7 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">F508del/F508del \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Hepatomegaly \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">↑ Persistent aspartate aminotransferase/alanine aminotransferase/Alkaline Phosphatase \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Hepatomegaly<br>↑ of hepatic echogenicity<br>Hepatic steatosis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">– \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">Normal \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1868956.png" ] ] ] "notaPie" => array:2 [ 0 => array:3 [ "identificador" => "tblfn0040" "etiqueta" => "a" "nota" => "<p class="elsevierStyleNotepara" id="npar0040">Age at start in months.</p>" ] 1 => array:3 [ "identificador" => "tblfn0045" "etiqueta" => "b" "nota" => "<p class="elsevierStyleNotepara" id="npar0045">Persistent increase: longer than six months.</p>" ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0070" class="elsevierStyleSimplePara elsevierViewall">Clinical presentation of patients from a referral center with hepatobiliary disease associated with cystic fibrosis, between January 2008 and June 2016.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:26 [ 0 => array:3 [ "identificador" => "bib0135" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Liver disease in cystic fibrosis: an update" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "G.F. Parisi" 1 => "G. Di Dio" 2 => "A. Gennaro" 3 => "N. Rotolo" 4 => "E. Salvatori" 5 => "E. Lionetti" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Hepat Mon" "fecha" => "2013" "volumen" => "35" "paginaInicial" => "783" "paginaFinal" => "790" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0140" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Triagem diagnóstica da hepatopatia da fibrose cística" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "E.D. Fagundes" 1 => "M.L. Roquete" 2 => "F.J. Penna" 3 => "F.J. Reis" 4 => "C.G. Duque" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Pediatr (Rio J)" "fecha" => "2002" "volumen" => "78" "paginaInicial" => "389" "paginaFinal" => "396" ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0145" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Liver disease in cystic fibrosis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "C. Colombo" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/MCP.0b013e3282f10a16" "Revista" => array:6 [ "tituloSerie" => "Curr Opin Pulm Med" "fecha" => "2007" "volumen" => "13" "paginaInicial" => "529" "paginaFinal" => "536" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17901760" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0150" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Analysis of risk factors for the development of liver disease associated with cystic fibrosis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C. Colombo" 1 => "M.G. Apostolo" 2 => "M. Ferrari" 3 => "M. Seia" 4 => "S. Genoni" 5 => "A. Giunta" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Pediatr (Rio J)" "fecha" => "1994" "volumen" => "124" "paginaInicial" => "393" "paginaFinal" => "939" ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0155" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The evolution of liver disease in cystic fibrosis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "S.C. Ling" 1 => "J.D. Wilkinson" 2 => "A.S. Hollman" 3 => "J. McColl" 4 => "T.J. Evans" 5 => "J.Y. Paton" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Arch Dis Child" "fecha" => "1999" "volumen" => "81" "paginaInicial" => "129" "paginaFinal" => "132" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10490519" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0160" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Natural history of liver disease in cystic fibrosis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "A. Lindblad" 1 => "H. Glaumann" 2 => "B. Strandvik" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/hep.510300527" "Revista" => array:6 [ "tituloSerie" => "Hepatology" "fecha" => "1999" "volumen" => "30" "paginaInicial" => "1151" "paginaFinal" => "1158" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10534335" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0165" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Liver disease in cystic fibrosis: a prospective study on incidence, risk factors, and outcome" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C. Colombo" 1 => "P.M. Battezzati" 2 => "A. Crosignani" 3 => "A. Morabito" 4 => "D. Costantini" 5 => "R. Padoan" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Pediatr (Rio J)" "fecha" => "2002" "volumen" => "36" "paginaInicial" => "1374" "paginaFinal" => "1382" ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0170" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Epidemiology of liver disease in cystic fibrosis: a longitudinal study" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "T. Lamireau" 1 => "S. Monnereau" 2 => "A. Martin" 3 => "J.E. Marcotte" 4 => "M. Winnock" 5 => "F. Alvarez" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jhep.2004.08.006" "Revista" => array:6 [ "tituloSerie" => "J Hepatol" "fecha" => "2004" "volumen" => "41" "paginaInicial" => "920" "paginaFinal" => "925" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15582124" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0175" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cystic fibrosis-related liver disease: a single-center experience" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "P.C. Costa" 1 => "C.C. Barreto" 2 => "L. Pereira" 3 => "M.L. Lobo" 4 => "M.A. Costa" 5 => "A.I. Lopes" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Pediatr Rep" "fecha" => "2011" "volumen" => "3" "paginaInicial" => "87" "paginaFinal" => "90" ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0180" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Liver involvement in the Hispanic population of North America with cystic fibrosis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "J.S. Wagener" 1 => "M.S. Woo" 2 => "D.J. Pasta" 3 => "M.W. Konstan" 4 => "W.J. Morgan" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/MPG.0000000000000448" "Revista" => array:6 [ "tituloSerie" => "J Pediatr Gastroenterol Nutr" "fecha" => "2014" "volumen" => "59" "paginaInicial" => "476" "paginaFinal" => "479" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24897167" "web" => "Medline" ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0185" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Non pulmonary chronic diseases in adults with cystic fibrosis: analysis of data from the Cystic Fibrosis Registry" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "R. Somerville" 1 => "A. Lackson" 2 => "S. Zhou" 3 => "C. Fletcher" 4 => "P. Fitzpatrick" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Ir Med J" "fecha" => "2013" "volumen" => "106" "paginaInicial" => "166" "paginaFinal" => "168" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23909150" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0190" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Liver disease in cystic fibrosis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "N. Kobelska-Dubiel" 1 => "B. Klincewicz" 2 => "W. Cichy" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.5114/pg.2014.43574" "Revista" => array:6 [ "tituloSerie" => "Prz Gastroenterol" "fecha" => "2014" "volumen" => "9" "paginaInicial" => "136" "paginaFinal" => "141" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25097709" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0195" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Gastrointestinal, pancreatic, and hepatobiliary manifestations of cystic fibrosis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "M.N. Sathe" 1 => "A.J. Freeman" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.pcl.2016.04.008" "Revista" => array:7 [ "tituloSerie" => "Pediatr Clin North Am" "fecha" => "2016" "volumen" => "63" "paginaInicial" => "679" "paginaFinal" => "698" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27469182" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S0039606017306761" "estado" => "S300" "issn" => "00396060" ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0200" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prognosis in cystic fibrosis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "S.G. Williams" 1 => "K.M. Hayller" 2 => "M.E. Hodson" 3 => "D. Westaby" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "1992" "volumen" => "327" "paginaInicial" => "1244" "paginaFinal" => "1245" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/1406813" "web" => "Medline" ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0205" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Análise crítica dos escores de avaliação de gravidade da fibrose cística: estado da arte" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "C.I. Santos" 1 => "J.D. Ribeiro" 2 => "A.F. Ribeiro" 3 => "G. Hessel" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Bras Pneumol" "fecha" => "2004" "volumen" => "30" "paginaInicial" => "286" "paginaFinal" => "298" ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0210" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Rapid silver staining and recovery of PCR products separated on polyacrylamide gels" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "C.J. Sanguinetti" 1 => "E. Dias Neto" 2 => "A.J. Simpson" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Biotechniques" "fecha" => "1994" "volumen" => "17" "paginaInicial" => "915" "paginaFinal" => "919" ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0215" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cystic fibrosis: a clinical view" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "C. Castellani" 1 => "B.M. Assael" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00018-016-2393-9" "Revista" => array:6 [ "tituloSerie" => "Cell Mol Life Sci" "fecha" => "2017" "volumen" => "74" "paginaInicial" => "129" "paginaFinal" => "140" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/27709245" "web" => "Medline" ] ] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib0220" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cystic fibrosis liver disease – from diagnosis to risk factors" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "I.M. Ciucã" 1 => "L. Pop" 2 => "L. Tãmas" 3 => "S. Tãban" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Rom J Morphol Embryol" "fecha" => "2014" "volumen" => "55" "paginaInicial" => "91" "paginaFinal" => "95" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24715171" "web" => "Medline" ] ] ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib0225" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Liver cirrhosis in cystic fibrosis – therapeutic implications and long term follow up" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "J. Feigelson" 1 => "C. Anagnostopoulos" 2 => "M. Poquet" 3 => "Y. Pecau" 4 => "A. Munck" 5 => "J. Navarra" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "Arch Dis Child" "fecha" => "1993" "volumen" => "68" "paginaInicial" => "653" "paginaFinal" => "657" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8280210" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S0039606015006686" "estado" => "S300" "issn" => "00396060" ] ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib0230" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Clinical and genetic risk factors for cystic fibrosis-related liver disease" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Wilschanski" 1 => "J. Rivlin" 2 => "S. Cohen" 3 => "A. Augarten" 4 => "H. Blau" 5 => "M. Aviram" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Pediatrics" "fecha" => "1999" "volumen" => "103" "paginaInicial" => "52" "paginaFinal" => "57" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9917439" "web" => "Medline" ] ] ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib0235" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Genotype analysis for DF508, G551D and R553X mutations in children and young adults with cystic fibrosis with or without liver disease" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A. Duthie" 1 => "D.G. Doherty" 2 => "C. Williams" 3 => "R. Scott-Jupp" 4 => "J.O. Warner" 5 => "M.S. Tanner" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Hepatology" "fecha" => "1992" "volumen" => "15" "paginaInicial" => "660" "paginaFinal" => "664" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/1551644" "web" => "Medline" ] ] ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib0240" "etiqueta" => "22" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Manifestações gastrointestinais na fibrose cística" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "L.R. Machado" 1 => "C.D. Ricachinevsky" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Rev HCPA" "fecha" => "2011" "volumen" => "31" "paginaInicial" => "185" "paginaFinal" => "191" ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib0245" "etiqueta" => "23" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cirrhosis and other liver disease in cystic fibrosis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "T. Flass" 1 => "M.R. Narcewicz" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jcf.2012.11.010" "Revista" => array:6 [ "tituloSerie" => "J Cyst Fibros" "fecha" => "2013" "volumen" => "12" "paginaInicial" => "116" "paginaFinal" => "124" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23266093" "web" => "Medline" ] ] ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib0250" "etiqueta" => "24" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Genetic modifiers of liver disease in cystic fibrosis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J.R. Bartlett" 1 => "K.J. Friedman" 2 => "S.C. Ling" 3 => "R.G. Pace" 4 => "S.C. Bell" 5 => "B. Bourke" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/jama.2009.1295" "Revista" => array:6 [ "tituloSerie" => "JAMA" "fecha" => "2009" "volumen" => "302" "paginaInicial" => "1076" "paginaFinal" => "1083" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19738092" "web" => "Medline" ] ] ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib0255" "etiqueta" => "25" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Fatores de risco da hepatopatia da fibrose cística" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "E.D. Fagundes" 1 => "M.L. Roquete" 2 => "F.J. Penna" 3 => "F.J. Reis" 4 => "E.M. Goulart" 5 => "C.G. Duque" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J Pediatr (Rio J)" "fecha" => "2005" "volumen" => "81" "paginaInicial" => "196" "paginaFinal" => "478" ] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib0260" "etiqueta" => "26" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cytomegalovirus" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "R.F. Pass" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "LibroEditado" => array:5 [ "titulo" => "Principles and practice of pediatric infectious diseases" "paginaInicial" => "1044" "paginaFinal" => "1058" "edicion" => "4th ed." "serieFecha" => "2012" ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/00217557/0000009400000005/v1_201810100616/S002175571730044X/v1_201810100616/en/main.assets" "Apartado" => array:4 [ "identificador" => "10179" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Original articles" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/00217557/0000009400000005/v1_201810100616/S002175571730044X/v1_201810100616/en/main.pdf?idApp=UINPBA000049&text.app=https://jped.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S002175571730044X?idApp=UINPBA000049" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 4 | 1 | 5 |
2024 October | 24 | 40 | 64 |
2024 September | 26 | 31 | 57 |
2024 August | 35 | 35 | 70 |
2024 July | 32 | 35 | 67 |
2024 June | 22 | 13 | 35 |
2024 May | 19 | 6 | 25 |
2024 April | 25 | 23 | 48 |
2024 March | 28 | 19 | 47 |
2024 February | 19 | 22 | 41 |
2024 January | 24 | 28 | 52 |
2023 December | 13 | 22 | 35 |
2023 November | 25 | 28 | 53 |
2023 October | 23 | 37 | 60 |
2023 September | 17 | 37 | 54 |
2023 August | 19 | 19 | 38 |
2023 July | 19 | 22 | 41 |
2023 June | 16 | 13 | 29 |
2023 May | 19 | 16 | 35 |
2023 April | 17 | 15 | 32 |
2023 March | 39 | 20 | 59 |
2023 February | 31 | 17 | 48 |
2023 January | 17 | 14 | 31 |
2022 December | 51 | 26 | 77 |
2022 November | 16 | 20 | 36 |
2022 October | 39 | 29 | 68 |
2022 September | 25 | 32 | 57 |
2022 August | 24 | 48 | 72 |
2022 July | 30 | 33 | 63 |
2022 June | 19 | 33 | 52 |
2022 May | 20 | 29 | 49 |
2022 April | 32 | 34 | 66 |
2022 March | 26 | 45 | 71 |
2022 February | 24 | 33 | 57 |
2022 January | 13 | 17 | 30 |
2021 December | 18 | 20 | 38 |
2021 November | 13 | 17 | 30 |
2021 October | 12 | 22 | 34 |
2021 September | 6 | 8 | 14 |
2021 August | 6 | 10 | 16 |
2021 July | 7 | 0 | 7 |
2021 June | 10 | 10 | 20 |
2021 May | 12 | 12 | 24 |
2021 April | 10 | 10 | 20 |
2021 March | 17 | 7 | 24 |
2021 February | 6 | 2 | 8 |
2021 January | 10 | 12 | 22 |
2020 December | 13 | 8 | 21 |
2020 November | 7 | 6 | 13 |
2020 October | 3 | 6 | 9 |
2020 September | 12 | 10 | 22 |
2020 August | 2 | 1 | 3 |
2020 July | 5 | 8 | 13 |
2020 June | 4 | 3 | 7 |
2020 May | 5 | 2 | 7 |
2020 April | 8 | 10 | 18 |
2020 March | 2 | 8 | 10 |
2020 February | 12 | 27 | 39 |
2020 January | 12 | 16 | 28 |
2019 December | 4 | 5 | 9 |
2019 November | 3 | 3 | 6 |
2019 October | 9 | 13 | 22 |
2019 September | 8 | 6 | 14 |
2019 August | 7 | 11 | 18 |
2019 July | 10 | 14 | 24 |
2019 June | 10 | 8 | 18 |
2019 May | 10 | 7 | 17 |
2019 April | 14 | 6 | 20 |
2019 March | 13 | 11 | 24 |
2019 February | 3 | 5 | 8 |
2019 January | 9 | 7 | 16 |
2018 December | 9 | 9 | 18 |
2018 November | 46 | 5 | 51 |
2018 October | 221 | 27 | 248 |
2018 September | 69 | 7 | 76 |
2018 August | 12 | 4 | 16 |
2018 July | 9 | 2 | 11 |
2018 June | 3 | 3 | 6 |
2018 May | 12 | 3 | 15 |
2018 April | 1 | 2 | 3 |
2018 March | 3 | 9 | 12 |
2018 February | 0 | 4 | 4 |
2018 January | 1 | 3 | 4 |
2017 December | 2 | 0 | 2 |
2017 November | 0 | 4 | 4 |
2017 October | 1 | 10 | 11 |
2017 September | 0 | 2 | 2 |